Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder
Open Access
- 9 August 2021
- journal article
- letter
- Published by Oxford University Press (OUP) in Brain
- Vol. 144 (10), e85
- https://doi.org/10.1093/brain/awab297
Abstract
With great interest we read the article by Diaz and colleagues 1 providing further evidence of a neurodevelopmental disorder caused by bi-allelic variants disrupting the function of YIF1B, by reporting a second patient cohort and a mouse model. We had earlier reported six individuals from five unrelated families, harbouring bi-allelic protein truncating mutations in YIF1B, presenting with a progressive encephalopathy with various degrees of movement disorders, microcephaly and epilepsy. 2Funding Information
- China Scholarship Council
- CSC (201906300026)
- Erasmus Medical Center, Rotterdam (PI19/01155, B2017/BMD-3721)
- King Abdullah University of Science and Technology (FCC/1/1976–25, REI/1/4446–01)
- KFSHRC (RAC2120022)
- King Salman Center for Disability Research (KSCDR#2180 004)
- King Abdulaziz City for Science and Technology (KACST#14-MED2007-20)
- Netherlands Organization for Scientific Research (91617021)
This publication has 7 references indexed in Scilit:
- Delineating the molecular and phenotypic spectrum of the SETD1B-related syndromeGenetics in Medicine, 2021
- Bi-allelic variants in HOPS complex subunit VPS41 cause cerebellar ataxia and abnormal membrane traffickingBrain, 2021
- YIF1B mutations cause a post-natal neurodevelopmental syndrome associated with Golgi and primary cilium alterationsBrain, 2020
- Truncating mutations in YIF1B cause a progressive encephalopathy with various degrees of mixed movement disorder, microcephaly, and epilepsyActa Neuropathologica, 2020
- Lysosomal targeting of the ABC transporter TAPL is determined by membrane-localized charged residuesOnline Journal of Public Health Informatics, 2019
- Yif1B Is Involved in the Anterograde Traffic Pathway and the Golgi ArchitectureTraffic, 2015
- A New Vesicular Scaffolding Complex Mediates the G-Protein-Coupled 5-HT1AReceptor Targeting to Neuronal DendritesJournal of Neuroscience, 2012